secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001104659-24-098792
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia raises ~$100M from stock offerings and RIFA advance for YUTREPIA development
--------------------------------------------------------------------------------

- Public offering of 6,460,674 shares at $8.90/share for ~$57.5M gross; private placement of 1,123,595 shares at $8.90/share for $10M.
- Fifth Amendment to RIFA with HCR provides additional $32.5M, bringing total RIFA to $100M; funding condition met upon stock offering close.
- Modified fixed payment schedule extends RIFA termination from 2029 to 2031; $23.8M payment deferred to 2026.
- Proceeds to fund YUTREPIA commercial development, pediatric/WHO Group 1/3 trials, and L606 clinical development.
- BofA Securities sole bookrunner; fund affiliated with Paul Manning invested ~$3M in offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924098792/0001104659-24-098792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924098792/tm2423751d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-098792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer